Cronos Group Inc. (CRON) Research

Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.

Market snapshot

Symbol
CRON
Price
$2.71
Day change
+1.50%
Market cap
$1.0B
P/E ratio
-501.06x
52-week range
1.84-3.43
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months
Analyst price target
$2.30

Peer companies

  • Amphastar Pharmaceuticals, Inc. (AMPH)
  • BridgeBio Oncology Therapeutics Inc. (BBOT)
  • Collegium Pharmaceutical, Inc. (COLL)
  • Embecta Corp. (EMBC)
  • IRadimed Corporation (IRMD)
  • Nurix Therapeutics, Inc. (NRIX)
  • Pacira BioSciences, Inc. (PCRX)
  • Phathom Pharmaceuticals, Inc. (PHAT)

Recent insider activity

  • Doucet Terrence Gregory Joseph — M-Exempt (10597 shares) on 2026-05-12
  • Doucet Terrence Gregory Joseph — M-Exempt (10597 shares) on 2026-05-12
  • Doucet Terrence Gregory Joseph — F-InKind (5199 shares) on 2026-05-12
  • Wagner Adam — M-Exempt (10367 shares) on 2026-05-12
  • Wagner Adam — M-Exempt (10367 shares) on 2026-05-12

Open Cronos Group Inc. (CRON) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.